FDA-2024-0061-V161

Type IB variation for application FDA-2024-0061. Type IB variation: Analytical Method Change for Infectivir — routine update

Variation Number
FDA-2024-0061-V161
Type
Type IB
Application
FDA-2024-0061
Change
CHG-2024-0161
Status
Pending
Fee
€1,002
Submitted
2023-06-10
Approved
—
Description

Type IB variation: Analytical Method Change for Infectivir — routine update